Product Code: GVR-1-68038-416-1
Atherectomy Devices Market Growth & Trends:
The global atherectomy devices market size is expected to reach USD 1,648.2 million by 2030, expanding at a CAGR of 8.1% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease. Favorable patient outcomes with minimally invasive procedures is also driving demand of atherectomy devices for peripheral vascular interventions.
New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2018, Cardiovascular Systems, Inc. (CSI) signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device. The agreement gave CSI an opportunity to leverage Aerolase's FDA cleared proprietary laser technology. The new laser atherectomy system will be used for treating multiple forms of peripheral arterial diseases
Atherectomy Devices Market Report Highlights:
- In 2022, the directional atherectomy segment held the largest market share owing to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.
- Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.
- Geographically, North America held the largest market share in 2022 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.
- Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Atherectomy Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Atherectomy Devices Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic Landscape
Chapter 4. Atherectomy Devices: Type Estimates & Trend Analysis
- 4.1. Atherectomy Devices Market: Key Takeaways
- 4.2. Atherectomy Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Directional Atherectomy
- 4.3.1. Directional atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Rotational Atherectomy
- 4.4.1. Rotational atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Orbital Atherectomy
- 4.5.1. Orbital atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Laser Atherectomy
- 4.6.1. Laser atherectomy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Atherectomy Devices Market: Regional Estimates & Trend Analysis
- 5.1. Regional Outlook
- 5.2. Atherectomy Devices Market by Region: Key Takeaway
- 5.3. North America
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.3.2. U.S.
- 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.3.3. Canada
- 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4. Europe
- 5.4.1. UK
- 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.2. Germany
- 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.3. France
- 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.4. Italy
- 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.5. Spain
- 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.6. Sweden
- 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.7. Norway
- 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.8. Denmark
- 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5. Asia Pacific
- 5.5.1. Japan
- 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.2. China
- 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.3. India
- 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.4. Australia
- 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.5. Thailand
- 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.6. South Korea
- 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6. Latin America
- 5.6.1. Brazil
- 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6.2. Mexico
- 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6.3. Argentina
- 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7. MEA
- 5.7.1. Saudi Arabia
- 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.2. South Africa
- 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.3. UAE
- 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.4. Kuwait
- 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Market Participant Categorization
- 6.2.1. Boston Scientific Corporation
- 6.2.1.1. Company overview
- 6.2.1.2. Financial performance
- 6.2.1.3. Product benchmarking
- 6.2.1.4. Strategic initiatives
- 6.2.2. Cardiovascular Systems, Inc.
- 6.2.2.1. Company overview
- 6.2.2.2. Financial performance
- 6.2.2.3. Product benchmarking
- 6.2.2.4. Strategic initiatives
- 6.2.3. Medtronic
- 6.2.3.1. Company overview
- 6.2.3.2. Financial performance
- 6.2.3.3. Product benchmarking
- 6.2.3.4. Strategic initiatives
- 6.2.4. Avinger
- 6.2.4.1. Company overview
- 6.2.4.2. Financial performance
- 6.2.4.3. Product benchmarking
- 6.2.4.4. Strategic initiatives
- 6.2.5. Koninklijke Philips N.V.
- 6.2.5.1. Company overview
- 6.2.5.2. Financial performance
- 6.2.5.3. Product benchmarking
- 6.2.5.4. Strategic initiatives
- 6.2.6. BD
- 6.2.6.1. Company overview
- 6.2.6.2. Financial performance
- 6.2.6.3. Product benchmarking
- 6.2.6.4. Strategic initiatives
- 6.2.7. Abbott
- 6.2.7.1. Company overview
- 6.2.7.2. Financial performance
- 6.2.7.3. Product benchmarking
- 6.2.7.4. Strategic initiatives
- 6.2.8. Cordis
- 6.2.8.1. Company overview
- 6.2.8.2. Financial performance
- 6.2.8.3. Product benchmarking
- 6.2.8.4. Strategic initiatives
- 6.2.9. Terumo Medical Corporation
- 6.2.9.1. Company overview
- 6.2.9.2. Financial performance
- 6.2.9.3. Product benchmarking
- 6.2.9.4. Strategic initiatives